MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Gaucher’s disease (GD) and Parkinsonism: An analysis from patients to relatives

I. Trezzi, E. Monfrini, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappelllini, A. Di Fonzo (Milan, Italy)

Meeting: 2018 International Congress

Abstract Number: 1328

Keywords: Lysosomal disorders, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To identify parkinsonian features in a cohort of GD patients and their relatives.

Background: GD is a lysosomal storage disorder caused by GBA1 mutations which are by far considered the major genetic risk factor for PD. An increased risk of developing PD has been observed in both GD patients and carriers.

Methods: We evaluated 21 GD patients and their relatives by performing a neurological examination and an interview focused on Parkinson’s Disease (PD) familiarity and non-motor symptoms.

Results: N370S was the most common mutation found in our cohort (16; 76%) whereas L444P was present in three patients (14%) of whom only one was homozygous (5%). The majority of them (80%) was diagnosed during childhood after detecting hepatosplenomegaly and thrombocytopenia. Neurologic manifestations were detected in eleven patients (52%), seven (33%) of which showed parkinsonian features, especially reduced limb synkinesis and tremor (4, 19%), rigidity and bradykinesia (3; 14%). Only one patient (1/21, 5%) was diagnosed with PD at the age of 52. Non-motor symptoms were present in nine GD patients (42%), especially RBD (6; 28%), constipation (4; 19%) and depression (3; 14%). Familiarity for parkinsonian symptoms was found in 15 (71%) GD families and in 10 (47%) of them there was at least one family member with PD.

Conclusions: We found an high incidence of motor and non-motor parkinsonian symptoms in our GD cohort. The incidence of PD was also increased in their relatives. Characterizing GD patients/relatives with parkinsonism may help to elucidate the mechanisms underlying this association and potential prognostic indicators for PD.

References: O. Neudorfer et al,, Occurrence of Parkinson’s syndrome in type I Gaucher disease, Q ; Med 1996; 89:691-694; G. Lopez et al., Clinical course and prognosis in patients with Gaucher disease and parkinsonism, Neurology, 2016.

To cite this abstract in AMA style:

I. Trezzi, E. Monfrini, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappelllini, A. Di Fonzo. Gaucher’s disease (GD) and Parkinsonism: An analysis from patients to relatives [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/gauchers-disease-gd-and-parkinsonism-an-analysis-from-patients-to-relatives/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/gauchers-disease-gd-and-parkinsonism-an-analysis-from-patients-to-relatives/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley